Back to Parexel Insights

Cell and Gene therapies: Evolving market dynamics and future potential

By Wyatt Gotbetter, Senior Vice President, Worldwide Head of Access Consulting
Ned Wydysh, Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Alicia Shields, Ph.D., Strategy Consultant, Cell and Gene Therapy Practice, Health Advances
Vivek Mittal, Ph.D., Partner and Managing Director, Head of Biopharma, Health Advances

30 min

A panel discussion about changing business models, technological advances, and improved safety.

Contributing Experts

Alicia Shields, Ph.D.

Strategy Consultant, Cell and Gene Therapy Practice, Health Advances

Read bio

Ned Wydysh

Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances

Read bio

Vivek Mittal, Ph.D.

Partner and Managing Director, Head of Biopharma, Health Advances

Read bio

Wyatt Gotbetter

SVP, Worldwide Head of Access Consulting

Read bio